We analyzed tumor mutation burden in the high-risk and low-risk groups, identifying tumor protein P53 (TP53), titin (TTN), and mucin 16 (MUC16) as the top mutated genes and missense variations constituting the predominant mutation type (Fig. S7A, B). This evidence concerns the gene TP53 and neoplasm.